Korea Pharm

Korea Pharma is a South Korean pharmaceutical company specializing in the development, manufacturing, and distribution of prescription drugs, with a strong focus on Central Nervous System (CNS) and gastrointestinal disorders. Founded in 1974, the company operates advanced manufacturing facilities that provide Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) services to global and domestic partners. Their product portfolio includes treatments for schizophrenia, depression, dementia, and various digestive ailments. Korea Pharma is also active in R&D, focusing on improved formulations and new drug candidates for unmet medical needs. The company is publicly traded on the KOSDAQ exchange under the ticker 232330.